The emerging treatment of the medication represents a significant breakthrough in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide372752.bloggin-ads.com/65179926/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment